Regulatory affairs as they affect invasive cardiology.

J Invasive Cardiol

IsoStent, Inc., 14600 Viburnum Drive, Dayton, Maryland 21036, USA.

Published: February 2001

Over the last several years, the United States Food and Drug Administration (FDA) has significantly improved the time required for the approval of PMA and PMA supplement applications. By the year 1999, the average approval time for PMA applications was 12 months and the average approval time for PMA supplements was only 4 months. In spite of this improved performance by the FDA, it is still advantageous for many products to have their first clinical trial outside the United States.

Download full-text PDF

Source

Publication Analysis

Top Keywords

united states
8
average approval
8
approval time
8
time pma
8
regulatory affairs
4
affairs affect
4
affect invasive
4
invasive cardiology
4
cardiology years
4
years united
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!